New imaging test could spot hidden breast cancers in dense tissue
NCT ID NCT03220893
Summary
This study tested whether adding a newer imaging method called molecular breast imaging (MBI) to standard 3D mammography (DBT) helps find more invasive breast cancers in women with dense breast tissue. Over 3,000 women aged 40-75 with dense breasts underwent both screening tests for two years. The goal was to see if the combined approach detects cancers that might be missed by mammography alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Henry Ford Hospital
Detroit, Michigan, 48202, United States
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
-
Mayo Clinic Health System-Franciscan Healthcare
La Crosse, Wisconsin, 54601, United States
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
-
Toledo Clinic Cancer Centers-Toledo
Toledo, Ohio, 43623, United States
Conditions
Explore the condition pages connected to this study.